Universality of Tumor Transformation Mechanisms
In pathophysiology, there is a fundamental rule: despite the enormous diversity of etiologic factors (chemical, physical, or biological carcinogens) and clinical forms of neoplasms, the cellular mechanism of disease development is always universal.
The ultimate result of any carcinogenic exposure is tumor transformation. This is driven by profound disruptions in the regulation of the cellular genome. While a healthy cell maintains strict checkpoints, carcinogenesis bypasses these controls through two parallel processes:
- Activation of the expression of oncogenes (genes that stimulate tumor growth).
- Depression or complete suppression of anti-oncogenes (tumor suppressors that normally halt the cell cycle).
This fundamental process is entirely universal. It follows a uniform scenario regardless of the initial mutation's trigger, the histological structure of the future tumor, or its anatomical location in the body.
Stage I: Action of Carcinogens on the Genome
The entire process of oncogenesis is traditionally divided into four sequential stages.
Stage One involves the impact of initiating factors on the genetic apparatus of a normal cell. The core of this stage is the primary interaction between the carcinogen and the cellular genome. The main targets for damaging agents are proto-oncogenes (precursors to oncogenes) and tumor suppressors.
Carcinogenic agents can include:
- Chemical and physical agents, as well as non-viral biological factors.
- DNA-containing oncogenic viruses, which directly inject their genetic material.
- RNA-containing oncogenic viruses. Their mechanism is more complex: to integrate into the host genome, they use a specific enzyme—reverse transcriptase. Using this enzyme, the virus synthesizes a DNA copy (known as a DNA provirus), which is subsequently integrated into the host cell chromosome.
Stage II: Transformation of Proto-oncogenes into Oncogenes
Stage Two is a critical turning point of genetic restructuring. Its core feature is the conversion of a normal proto-oncogene into a hyperactive oncogene, accompanied by the mandatory suppression of tumor suppressor activity.
This transformation is realized through several specific genetic alterations (mutations):
- Point mutation of a cellular oncogene (c-onc), altering the structure of the encoded protein.
- Amplification of c-onc—a multiple increase in gene copy number, leading to an overproduction of its product.
- Translocation of c-onc—transfer of a chromosomal segment containing the oncogene to a new position where it undergoes active transcription.
- Insertion of a heterotopic promoter, which artificially drives oncogene expression.
- Depression of anti-oncogenes—inactivation of the protective mechanisms that restrain tumor growth.
Stages III and IV: From Oncoprotein Synthesis to Tumor Mass Formation
Stage Three represents the actual tumor transformation of the cell. It is crucial to remember a key rule: oncogene expression is a necessary and fully sufficient condition for converting a normal cell into a malignant one.
At this stage, the active oncogene initiates robust synthesis of specific oncoproteins. These proteins exert their pathological effects either directly or indirectly via cellular growth factors and their membrane receptors. Under the influence of oncoproteins, the genotypically altered cell dramatically changes its properties and acquires a characteristic tumor phenotype.
Stage Four is the final stage of carcinogenesis, where the process transitions to the tissue level. The essence of this stage is the onset of uncontrolled division of the transformed cell. Stripped of regulatory checkpoints, the cell proliferates rapidly, ultimately resulting in the formation of a visible neoplasm—a tumor node.